Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection

Eur J Gastroenterol Hepatol. 2004 Oct;16(10):969-79. doi: 10.1097/00042737-200410000-00004.

Abstract

Objectives: Helicobacter pylori infection causes chronic gastritis and induces cyclooxygenase (COX)-2 expression. The relationship between gastritis and COX-2 expression is not well understood, especially long after the organism has been eradicated. We designed a study to elucidate this relationship.

Methods: Four endoscopic gastric biopsies from each of 118 H. pylori-infected subjects were assessed for COX-2 expression immunohistochemically, gastritis, by an updated Sydney System. In the 107 successfully eradicated subjects, the assessment was repeated once yearly, for 3 years.

Results: After successful eradication, COX-2 expression was reduced significantly regardless of site. Atrophy improved significantly and intestinal metaplasia improved but not in the antrum greater curvature. After 1 year COX-2 expression was not significantly different in the epithelia with and without intestinal metaplasia. Correlation between COX-2 expression and neutrophil score in the antrum (r = 0.214, P = 0.042) and inflammation in the corpus (r = 0.234, P = 0.025) disappeared after eradication. COX-2 expression correlated well with atrophy and metaplasia before and after eradication. No significant reduction in COX-2 or improvement in gastritis was found in subjects with eradication failure.

Conclusion: H. pylori infection is associated with the enhancement of COX-2 expression in the gastric mucosa. Eradication therapy reduces COX-2 expression and hence may reduce the risk of cancer development.

Publication types

  • Comparative Study

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Aged
  • Cyclooxygenase 2
  • Female
  • Follow-Up Studies
  • Gastric Mucosa / enzymology*
  • Gastric Mucosa / immunology
  • Gastritis / drug therapy
  • Gastritis / enzymology*
  • Gastritis / immunology
  • Gastroscopy
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / enzymology*
  • Helicobacter Infections / immunology
  • Helicobacter pylori*
  • Humans
  • Lansoprazole
  • Male
  • Membrane Proteins
  • Middle Aged
  • Neutrophil Activation
  • Omeprazole / analogs & derivatives*
  • Omeprazole / therapeutic use
  • Prostaglandin-Endoperoxide Synthases / analysis
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Proton Pump Inhibitors
  • Statistics, Nonparametric
  • Time Factors

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Membrane Proteins
  • Proton Pump Inhibitors
  • Lansoprazole
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Omeprazole